Keywords: elan/biogen, idec, antegren, filed, crohn, disease, eu

Elan/Biogen Idec's Antegren filed for Crohn's disease in EU

Article | 04 October 2004

Print This

USA-based Biogen Idec and Ireland's Elan Corp have submitted a Marketing Authorization Application to the European Medicines Agency for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in